Ovarian Cancer Coverage from Every Angle

Ursula A. Matulonis, MD, on Genetic Profiling and PARP Inhibitors

Posted: Monday, August 12, 2019

What have gene-profile analyses suggested about the role of PARP inhibitors in the future treatment of recurrent ovarian cancer?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.